October 17, 2019
As of November 15, 2019, Pfizer will no longer commercialize EMBEDA® CII (morphine sulfate and naltrexone hydrochloride) extended release capsules. Anticipated unavailability of the product is early 2020. This decision was not made because of any safety or efficacy issues, or because of manufacturing concerns. Patients should talk to their healthcare provider about other appropriate options to help manage their pain.